Stocks and Investing Stocks and Investing
Wed, August 12, 2015
Tue, August 11, 2015
Mon, August 10, 2015

Matt Miksic Initiated (ABT) at Buy with Increased Target to $55 on, Aug 10th, 2015


Published on 2024-10-25 09:40:44 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Initiated "Abbott Laboratories" (ABT) at Buy with Increased Target from $50 to $55 on, Aug 10th, 2015.

Matt has made no other calls on ABT in the last 4 months.



There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matt


  • Joanne Wuensch of "BMO Capital" Maintained at Buy with Increased Target to $56 on, Thursday, July 23rd, 2015
  • Vijay Kumar of "Evercore ISI Group" Initiated at Strong Buy and Held Target at $54 on, Wednesday, May 27th, 2015

Contributing Sources